trending Market Intelligence /marketintelligence/en/news-insights/trending/c991gqkz9feE8T4sSKH4Pg2 content esgSubNav
In This List

Antibe Therapeutics completes private placement, raises C$2.7M

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Antibe Therapeutics completes private placement, raises C$2.7M

Antibe Therapeutics Inc. completed the second and final closing of its private placement, raising another C$297,750 in gross proceeds to bolster the C$2.4 million raised in the first tranche of the offering.

The net proceeds of approximately C$2.7 million will be used for clinical development and general purposes.

The issued securities are subject to a four-month statutory hold period and a TSX Venture Exchange hold period, each expiring April 22, 2017.